What They Don't Tell You About Breast Cancer Recurrence
In this monologue, the speaker critiques the standard breast cancer care pathway—unnecessary full mastectomy and systemic chemotherapy driven by population‑health NCCN guidelines—arguing that such one‑size‑fits‑all treatment can suppress the immune system and facilitate metastasis. The speaker presents an alternative integrative oncology approach: using a Sinatra DX test to identify tumor characteristics, freezing the tumor early, and administering targeted micro‑doses of chemotherapy (around 10% of conventional dose) to stimulate the patient’s immune response. This strategy aims to engage natural killer (NK) cells, dendritic cells (DCs), and tumor neo‑antigens, creating a systemic immune reaction that can prevent recurrence, as illustrated by a case where cancer reappeared in the opposite breast after conventional treatment.
